NASDAQ · MTRY
Monterey Bio Acquisition Corporation
Financial Services · Shell Companies
$11.14
Down-$0.03 (-0.27%)
Updated Aug 13, 2026, 11:08 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 48.3M
- P/E ratio
- -25.14
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 4.24K
- Avg. volume
- 3.27K
Price performance
MTRY price history
1M range · 0 trading sessions · Daily adjusted prices
MTRY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest MTRY news
The latest Smart Investors Daily articles mentioning MTRY.
Stock researchCompany · Overview
MTRY research
Overview
Company profile and research snapshot.
Company profile
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
